Amide Proton Transfer (APT) imaging of brain tumors at 7T: the role of tissue water T1-relaxation properties
Vitaliy Khlebnikov1, Daniel Polders2, Jeroen Hendrikse1, Pierre A Robe1, Eduard H Voormolen1, Peter R Luijten1, Dennis WJ Klomp1, and Hans Hoogduin1

1Radiology, University Medical Center Utrecht, Utrecht, Netherlands, 2Philips Healthcare, Best, Netherlands

Synopsis

The purpose of this study was to provide insight into the effect of water-T1-relaxation (T1w) on Amide Proton Transfer (APT) contrast in tumors. To this end, three different metrics of APT contrast, (mainly novel magnetization transfer ratio (MTRRex), relaxation-compensated MTRRex (AREX) and traditional asymmetry (MTRasym)) were compared in normal and tumor tissues in a variety of intracranial tumors at 7T. The strong correlation of MTRRex and MTRasym with T1w and the absence thereof in AREX suggests that much of APT contrast in tumors at 7T originates from the inherent tissue water-T1-relaxation properties.

Target audience

Those interested in understanding of tumor Amide Proton Transfer (APT) contrast.

Purpose

The purpose of this study was to provide insight into the effect of water-T1-relaxation (T1w) on APT contrast in tumors. Three different metrics of APT contrast: three-point-method-based [1] magnetization transfer ratio (MTRRex, APT signal free from the effects of direct water saturation and conventional magnetization transfer) [2] and relaxation-compensated MTRRex (AREX) [2], and traditional asymmetry (MTRasym) [3] were compared in normal and tumor tissues in a variety of intracranial tumors at 7T.

Methods

Six consented patients with intracranial brain tumors were scanned on a 7T Philips MR system. A pulsed 3D steady-state CEST sequence [4] was used with the following parameters: saturation prepulse (a rectangular-shaped 1.8 μT 50 ms pulse followed by a 50 mT/m spoiler of 25ms) interleaved with a readout (segmented EPI, EPI factor of 15 with a binomial RF pulse for water only excitation, TR/TE/FA=106/6.4ms/18.5°, FOV 224x224x100 mm3, 2 mm isotropic); time per volume 20.3 s, inter-volume delay 2 s, total scan time 6min40s. A quantitative T1 map was obtained using the method in [5,6]. The 3T protocol included a T1-weighted post gadolinium (postGd-T1w) scan. A 7T fluid attenuated inversion recovery (FLAIR) [7] was used to visualize edema and cystic regions.All images were co-registered to the FLAIR images. Masks of normal and diseased tissues were drawn on postGd-T1w and FLAIR images (Fig. 1) by an experienced neuroradiologist. B0 was corrected by using WASSR [8]. All metrics were quantified in the range of 3 to 4 ppm to increase SNR.

Results and Discussion

The dependence of APT signal build-up on T1w of the mediating bulk water proton pool can be seen in Fig. 2 (left inset). The APT signal (area under the linear baseline) tends to increase as T1w of tissue increases. The same T1w dependence is obvious for traditional asymmetry analysis (MTRasym), shown in the right inset. An overview of the data of the six patients is shown in Fig. 3. While MTRasym is enhanced in tumor region in all cases, its contrast resembles that of the T1 map. The “randomness” of MTRrex and AREX is most likely an issue of pixel-wise implementation of the three-point method.Region-averaged APT assessments are often sufficient for diagnosis and assessment of therapy response. ROI analysis was performed on both normal and diseased tissues. As expected, a positive correlation was found between MTRRex of tissue types and their T1w values (Fig. 4 A, R=0.88, p<0.05), suggesting that the contribution of T1w effect to APT can be significant. Surprisingly, after T1w correction, there was no difference between normal and pathological tissues for AREX as demonstrated by the overlapping data points (Fig. 4 B, R=-0.21, p=0.69). Interestingly, the difference between low (Fig. 4 A, red open circles) and high grade (Fig. 4 B, red solid circles) glioma disappears for AREX, where the relaxation effects are accounted for. A strong positive correlation with T1w is also evident for MTRasym (Fig. 4 C, R=0.92, p<<0.05).

Conclusions

Much of APT contrast in tumors for the low-power 3D acquisition scheme at 7T, typically explained by an increase in the content endogenous amides, originates from the inherent-tissue-water-T1-relaxation properties.

Acknowledgements

This work was supported by the Initial Training Network, HiMR, funded by the FP7 Marie Curie Actions of the European Commission (FP7-PEOPLE-2012-ITN-316716).

References

[1] Jin T et al. MRM 2013. [2] Zaiss M et al NMRBiomed 2014. [3] Guivel-Scharen V et al. JMagnReson 1998. [4] Jones CK et al. MRM 2012. [5] Ordidge RJ et al. MRM 1990. [6] Polders DL et al. JMagnReson 2012. [7] Visser F et al. MRM. 2010. [8] Kim M et al. MRM 2009.

Figures

Fig. 1. (A) A T1 map of a patient with glioblastoma-multiforme (WHO 4). (B) postGd-T1w and (C) FLAIR images were used to define different tissues, classified as normally-appearing-white-matter (NAWM, ROI 1), edema (ROI 2), normally-appearing-gray matter (NAGM, ROI 3), Gd-enhanced-tumor (ROI 4), non-enhanced-solid-tumor (ROI 5) and non-enhanced-cysts (ROI 6).

Fig. 2. Whole-ROI-averaged CEST spectra of ROIs from Fig. 1. The left inset shows amplification of the APT region (3-4ppm). All CEST spectra in the inset are arranged in order of increasing tissue-water-T1-relaxation-times (top-bottom). The right inset shows amplification of MTRasym spectrum. See Fig. 1 for ROIs color-coding.

Fig. 3. An overview of all patients, showing through-tumor-single-slice images: (1) postGd-T1w, (2) FLAIR, (3) T1-map, (4) MTRRex, (5) AREX, and (6) MTRasym. Each row corresponds to a different case (top-bottom): meningioma (WHO grade 1), oligodendroglioma (WHO 2), oligo-actrocytoma (WHO 2), and the last three cases: glioblastoma-multiforme (WHO 4).

Fig. 4. Scatter plots of ROI-averaged-tissue-analysis of all patients for the three metrics of APT contrast. (A)MTRRex, (B)AREX and (C)MTRasym, are depicted as a function of tissue-water T1 (T1w). The linear black lines represent the linear regression relation between each APT metric and T1w. See Fig. 1 for ROIs color-coding.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1508